DexCom, Inc.
DXCM
Classifica tra le azioni
#757
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Prezzo delle azioni
$85.72
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$32.35B
Variazione (1 giorno)
-0.30%
Variazione (1 anno)
22.90%
Paese
US
Scambia DexCom, Inc. (DXCM)
Categoria
Healthcare
Ricavi di DexCom, Inc. (DXCM)
Ricavi nel Jun 2026 TTM: $4.97B
Secondo gli ultimi rapporti finanziari di DexCom, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $4.97B. Nel 2024, l'azienda ha registrato ricavi di $4.03B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $3.62B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per DexCom, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $4.97B | 6.59% |
| 2025 | $4.66B | 15.60% |
| 2024 | $4.03B | 11.34% |
| 2023 | $3.62B | 24.49% |
| 2022 | $2.91B | 18.84% |
| 2021 | $2.45B | 27.08% |
| 2020 | $1.93B | 30.54% |
| 2019 | $1.48B | 43.08% |
| 2018 | $1.03B | 43.58% |
| 2017 | $718.50M | 25.33% |
| 2016 | $573.30M | 42.61% |
| 2015 | $402.00M | 55.09% |
| 2014 | $259.20M | 62.00% |
| 2013 | $160.00M | 60.16% |
| 2012 | $99.90M | 30.99% |
| 2011 | $76.27M | 56.83% |
| 2010 | $48.63M | 63.78% |
| 2009 | $29.69M | 201.82% |
| 2008 | $9.84M | 112.62% |
| 2007 | $4.63M | 113.25% |
| 2006 | $2.17M | 0.00% |
| 2005 | 0.00 | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.59B | 837.47% |
US
|
|
| $35.48B | 614.08% |
IE
|
|
| $25.84B | 419.94% |
US
|
|
| $21.00B | 322.52% |
US
|
|
| - | - |
DE
|
